// App-Quantinova.ai

103 : JAK-STAT activation in anti-PD-1 therapy-associated granuloma annulare

Researchers

Presenter

  • R. Choi

Principal Investigators

  • J. Wang

  • W. Damsky

  • A. Wang

  • A. Galan

  • J.S. Leventhal

Medical Centers

  • Yale School of Medicine, New Haven, Connecticut, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Infectious Diseases (ID)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Squamous cell carcinoma of the head and neck

  • Lung Cancer

  • Sarcoidosis

  • Diabetes

  • Solid malignancies

Biomarkers

  • Signal Transducer And Activator Of Transcription 1

  • Signal transducer and activator of transcription 3

Drug/Treatment

  • Pembrolizumab

  • Tasocitinib

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved